| abstract |
PCT No. PCT/SE95/00678 Sec. 371 Date Jun. 22, 1995 Sec. 102(e) Date Jun. 22, 1995 PCT Filed Jun. 7, 1995 PCT Pub. No. WO96/01624 PCT Pub. Date Jan. 25, 1996A new pharmaceutical multiple unit tableted dosage form containing as active ingredient an acid labile H+K+-ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the method of treatment with such a formulation in medicine. |